This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Cramer's Action Alerts PLUS - See his portfolio and get alerts BEFORE every trade. Learn more NOW!

Analysts' Actions: JDSU CSCO BIG ARO AAP

Ubiquiti Networks (UBNT) downgraded at Pacific Crest to Sector Perform, Pacific Crest said. Sales are declining.

Ubiquiti Networks downgraded at Deutsche from Buy to Hold, Deutsche Bank said. $12 price target. Company guided lower, because of counterfeiting issues.

Ubiquiti Networks downgraded at Wedbush. Shares of UBNT downgraded to Neutral from Outperform, Wedbush said. $8 price target. Counterfeiting issue to take longer to resolve.

Verisign (VRSN) downgraded at Baird from Outperform to Neutral, Robert Baird said. Valuation call, based on a $47 price target.

STOCK COMMENTS / EPS CHANGES

Alliant Techsystems (ATK) numbers boosted at Credit Suisse. Shares of ATK now seen reaching $56, according to Credit Suisse. Estimates also upped, as the company is realizing higher margins. Neutral rating.

Enersys (ENS) numbers raised at Jefferies. Shares of ENS now seen reaching $43, Jefferies said. Estimates also raised on strong execution. Buy rating.

ExactTarget (ET) estimates, target raised at Lazard. Shares of ET now seen reaching $32, according to Lazard. Estimates also increased, given the company's new guidance.

JPMorgan (JPM) estimates cut at UBS through 2013, UBS said. Company has delayed its share buybacks. Buy rating and $46 price target.

Nordstrom (JWN) estimates, target raised at Credit Suisse. Shares of JWN now seen reaching $56, according to Credit Suisse. Estimates also increased, as the company is taking market share. Neutral rating.

Kohl's (KSS) numbers lowered at BMO Capital. Shares KSS now seen reaching $58, BMO Capital said. Estimates also lowered on gross margin threshold reset. Outperform rating.

Medivation (MDVN) estimates, target cut at Credit Suisse. Shares of MDVN now seen reaching $120, according to Credit Suisse. Estimates also reduced, given rising operating costs. Outperform rating.

Noble Energy (NBL) numbers increased at Guggenheim. NBL estimates were raised through 2013, Guggenheim said. New Falkland deal should add to earnings. Buy rating and new $120 price target.

NVIDIA (NVDA) numbers raised at BMO Capital. Shares of NVDA now seen reaching $16, BMO Capital said. Estimates also raised on strong results and guide. Market Perform rating.

ViroPharma (VPHM) numbers raised at Jefferies. Shares of VPHM now seen reaching $29, Jefferies said. Estimates also raised on solid 2Q12. Buy rating.

>To submit a news tip, email: tips@thestreet.com.

READERS ALSO LIKE:


Follow TheStreet on Twitter and become a fan on Facebook.

This article was written by a staff member of TheStreet.
2 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG
AAP $154.77 -0.10%
ARO $4.33 7.44%
BIG $48.88 2.45%
CSCO $30.19 2.30%
JDSU $13.81 0.29%

Markets

DOW 18,288.63 +155.93 0.86%
S&P 500 2,117.39 +12.89 0.61%
NASDAQ 5,008.0960 +44.5690 0.90%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs